Is Cytori Cell Research stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, Cytori Cell Research pays dividends. Last time was Thursday 1st of January 1970 where the investors holding the stock on Monday 30th of March 2020 were paid JPY10 per share. Over the last 3 times between 2018 and 2020, Cytori Cell Research has paid JPY40 with an average of JPY13.33 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Cytori Cell Research 10 years ago, but if you had invested on Friday 22nd of November 2019 when the price was JPY695.00, you would have made a profit of JPY152.00 per share or 21.87%
Yes, the average daily trading liquidity for Cytori Cell Research is JPY7 355 thousand. You should therefore be able to get in and out of your positions relatively fast.
Cytori Cell Research has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. Cytori Cell Research has a good net profit margin of 5.10% and should have high tolerances against inflation.
We have calculated the inflation risk for Cytori Cell Research to be medium [0.55 of 1]
US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.